Biophotonic compositions and methods for providing biophotonic treatment
AssigneeKlox Technologies Inc.
InventorsRemigio Piergallini, Nikolaos Loupis, Shipra Rastogi
Life of this patent
Estimating the term…
Abstract
The present disclosure provides biophotonic topical compositions and methods useful in phototherapy. In particular, the biophotonic topical compositions of the present disclosure are substantially resistant to leaching such that very low amounts of chromophore(s) present in the biophotonic composition leach out of the composition. The biophotonic compositions and the methods of the present disclosure are useful for promoting wound healing and skin rejuvenation, as well as treating acne and various skin disorders.
Claims22
A method for reducing scarring formation, comprising:
- topically applying a biophotonic composition to a scarred tissue, comprising a chromophore and a gelling agent;
- wherein the biophotonic composition is substantially translucent having a transmission of light of more than 20% and has a viscosity of between about 15 000 cP and about 100 000 cP;
- and
- illuminating said biophotonic composition with actinic light, wherein the actinic light delivers a power density of less than about 150 mW/cm2 when located at 5 cm from the scarred tissue and wherein the biophotonic composition is activatable upon being illuminated with the actinic light for a period between about 1 second and about 30 seconds;
- wherein the gelling agent renders the biophotonic composition substantially resistant to leaching such that less than 15% of a total amount of the chromophore leaches out of the biophotonic composition into tissue during treatment.
A method for reducing scarring formation during acne treatment, comprising:
- topically applying a biophotonic composition to a scarred tissue, comprising a chromophore and a gelling agent;
- wherein the biophotonic composition is substantially translucent having a transmission of light of more than 20% and has a viscosity of between about 15 000 cP and about 100 000 cP;
- and
- illuminating said biophotonic composition with actinic light;
- wherein the actinic light delivers a power density of less than about 150 mW/cm2 when located at 5 cm from the scarred tissue and wherein the biophotonic composition is activatable upon being illuminated with the actinic light for a period between about 1 second and about 30 seconds;
- wherein the gelling agent renders the biophotonic composition substantially resistant to leaching such that less than 15% of a total amount of the chromophore amount leaches out of the biophotonic composition into tissue during treatment.
Dependencies are inferred from the claim text.